Filing Details
- Accession Number:
- 0001543407-19-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-06 15:05:44
- Reporting Period:
- 2019-03-04
- Accepted Time:
- 2019-03-06 15:05:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1686270 | Alberto Ribo Mas | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Evp And Pres, Life Sciences | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-04 | 4,864 | $108.89 | 22,476 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-04 | 2,077 | $255.03 | 20,399 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2019-03-04 | 2,787 | $255.03 | 17,612 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-03-04 | 2,021 | $255.03 | 15,591 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2019-03-04 | 4,864 | $0.00 | 4,864 | $108.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,483 | 2014-11-26 | 2023-11-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,554 | Indirect | GSIP Trust |
| Common Stock | 1,055 | Indirect | SIP Trust |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $255 through $255.75. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
- Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of May 31, 2017.
- Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of July 31, 2017.
- The stock appreciation rights vest in four annual installments beginning November 26, 2014.
Billionaire Hedge Funds
